Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis - PubMed (original) (raw)
Review
. 2008 Oct;74(12):1423-9.
doi: 10.1055/s-2008-1081346. Epub 2008 Aug 5.
Affiliations
- PMID: 18683125
- DOI: 10.1055/s-2008-1081346
Review
Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis
Min Xu et al. Planta Med. 2008 Oct.
Abstract
Sinomenine (SIN), an alkaloid isolated from CAULIS SINOMENII, has been used in the treatment of rheumatoid arthritis (RA) clinically. This study aimed to systematically evaluate the efficacy and safety of SIN by a comparison between SIN and non-steroidal anti-inflammatory drugs (NSAIDs). Forty-three electronic databases were systematically searched. The quality of eligible trials was assessed by Jadad's scale. Revman 5.0 software was used for data syntheses and meta-analyses. The results showed that (i) of the 121 potential studies identified, 10 clinical trials involving 1185 patients met the inclusion criteria; (ii) improved patients and rheumatoid factor disappearance patients after SIN treatments were significantly more than those treated by NSAIDs ( P < 0.00001 and P = 0.008); (iii) compared with NSAIDs, SIN was more effective in amelioration of morning stiffness ( P < 0.00001), painful joints ( P = 0.03), and erythrocyte sedimentation rate ( P < 0.00001), but there was no significant difference between the two remedies in the treatment of swollen joints, grip strength, and C-reactive protein ( P > 0.05); and (iv) adverse events occurred less frequently in the digestive system during SIN treatment than during NSAID treatment ( P = 0.0003) but occurred more frequently in the dermatomucosal system with SIN treatment ( P = 0.03), while adverse events of the nervous system were similar for both treatments ( P = 0.31). In conclusion, SIN may be a valuable remedy to treat RA clinically, although current evidence needs to be further verified by more high-quality trials.
Similar articles
- Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis.
Liu W, Qian X, Ji W, Lu Y, Wei G, Wang Y. Liu W, et al. J Tradit Chin Med. 2016 Oct;36(5):564-77. doi: 10.1016/s0254-6272(16)30075-9. J Tradit Chin Med. 2016. PMID: 29932627 Review. - [Meta-analysis of efficacy and safety of sinomenine combined with methotrexate in treatment of rheumatoid arthritis].
Zeng C, Shuai YF, Li X. Zeng C, et al. Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(1):214-224. doi: 10.19540/j.cnki.cjcmm.20200322.501. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 33645073 Chinese. - Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review.
Li JM, Yao YD, Luo JF, Liu JX, Lu LL, Liu ZQ, Dong Y, Xie Y, Zhou H. Li JM, et al. Phytomedicine. 2023 Dec;121:155114. doi: 10.1016/j.phymed.2023.155114. Epub 2023 Sep 27. Phytomedicine. 2023. PMID: 37816287 Review. - A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis.
Guo X, Ji J, Feng Z, Hou X, Luo Y, Mei Z. Guo X, et al. Int Immunopharmacol. 2020 Mar;80:106201. doi: 10.1016/j.intimp.2020.106201. Epub 2020 Jan 20. Int Immunopharmacol. 2020. PMID: 31972421
Cited by
- An ultra-high performance liquid chromatographic-tandem mass spectrometric method for the determination of sinomenine in human plasma after transdermal delivery of the zhengqing fengtongning injection.
Chen T, Xiang Z, Dong G, Luo P, Qiu P, Wang S, Huang B, Wen Y, Wu F, Liu L, Zhou H. Chen T, et al. Molecules. 2015 Apr 10;20(4):6454-65. doi: 10.3390/molecules20046454. Molecules. 2015. PMID: 25867830 Free PMC article. - Methodological and reporting quality evaluation of meta-analyses on the Chinese herbal preparation Zheng Qing Feng Tong Ning for the treatment of rheumatoid arthritis.
Liang M, Yan L, Mei Z, Luo Y, Hou X, Feng Z. Liang M, et al. BMC Complement Med Ther. 2020 Jun 26;20(1):195. doi: 10.1186/s12906-020-02978-5. BMC Complement Med Ther. 2020. PMID: 32586308 Free PMC article. - Serum proteomic analysis of the anti‑arthritic effects of sinomenine on rats with collagen‑induced arthritis.
Qian X, Zhao Z, Shang W, Xu Z, Zhang B, Cai H. Qian X, et al. Mol Med Rep. 2018 Jul;18(1):49-58. doi: 10.3892/mmr.2018.8959. Epub 2018 May 3. Mol Med Rep. 2018. PMID: 29749546 Free PMC article. - Sinomenine Induces G1-Phase Cell Cycle Arrest and Apoptosis in Malignant Glioma Cells Via Downregulation of Sirtuin 1 and Induction of p53 Acetylation.
He X, Maimaiti M, Jiao Y, Meng X, Li H. He X, et al. Technol Cancer Res Treat. 2018 Jan 1;17:1533034618770305. doi: 10.1177/1533034618770305. Technol Cancer Res Treat. 2018. PMID: 29756546 Free PMC article. - Controlled release of optimized electroporation enhances the transdermal efficiency of sinomenine hydrochloride for treating arthritis in vitro and in clinic.
Feng S, Zhu L, Huang Z, Wang H, Li H, Zhou H, Lu L, Wang Y, Liu Z, Liu L. Feng S, et al. Drug Des Devel Ther. 2017 Jun 15;11:1737-1752. doi: 10.2147/DDDT.S136313. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28670109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous